[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"strabismic-deviation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:strabismic-deviation":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100606810","botulinum-toxin-for-strabismus-treatment-100606810",false,"NCT07180394","Botulinum Toxin for Strabismus Treatment","Botox Squint","Inclusion Criteria:\n\n* Esotropia or exotropia presenting with a small-to-moderate angle deviation (\\\u003C40 PD)\n\n  * Acute onset comitant esotropia\n  * Postoperative residual or consecutive strabismus (2-8 weeks postoperatively or later)\n  * Acute paralytic strabismus to alleviate diplopia while the palsy resolves (mainly sixth nerve palsies, sometimes fourth nerve palsy)\n  * Active thyroid eye disease (Graves Disease), inflamed or pre-phthisical eyes, when surgery is not recommended\n  * Adjunct to surgery for large-angle esotropia or sixth nerve palsy or for large-angle exotropia\n  * As a muscle sparing option in patients at risk of anterior segment ischemia\n\nExclusion Criteria:\n\n* Unrealistic expectations\n\n  * Neuromuscular disorders: Amyotrophic Lateral Sclerosis (ALS), Myasthenia Gravis and Eaton-Lambert syndrome\n  * Pregnancy and breastfeeding","ALL","1 Month",{"count":19,"type":20},127,"ESTIMATED","INTERVENTIONAL",[23],"NA","The bacterial species Clostridium botulinum produces a class of neurotoxins known as botulinum toxin. At the neuromuscular junction, botulinum toxin A prevents acetylcholine from being released. Following a Botox intramuscular injection, the injected EOM becomes paralysed 2-4 days after the injection and remains so clinically for at least 5-8 weeks. Muscle function recovery takes five to fourteen weeks, depending on the injection site, volume, and concentration of the solution, as well as the innervation density.\n\nBotulinum toxin treatment results in a pharmacologic recession of the injected extraocular muscle, and the muscle lengthens while its agonist contracts, paralysing it. Improved ocular alignment or a decrease in the severity of the deviation may last for a long time, even if the pharmaceutical impact normally goes away after three months.\n\nEven after the pharmacologic effect has worn off, a number of elements, such as mechanical, proprioceptive, and binocular effects, may intervene during the period of muscle paralysis to help stabilise and improve alignment in strabismus patients over the long term.",[26,27],"Strabismic Deviation","Strabismus",[27,29,30,31,32,33,34,35],"esotropia","exotropia","hypotropia","hypertropia","Botulinum toxin","therapy","outcomes","NOT_YET_RECRUITING","2025-09-15",{"date":39,"type":40},"2025-09-18","ACTUAL",{"date":42,"type":20},"2025-09-30",{"date":44,"type":20},"2030-08-30",{"name":46,"class":47},"Foundation University Islamabad","OTHER"]